Latest / Stock Movers / Alibaba and ON Rise; Viking Therapeutics Surges
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio, news. The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg data. Let's take a look
- 0:17Speaker 1: at some stocks on the move today.
- 0:18Speaker 2: So Alibaba, ticker symbol B-A-B-A, up better than 3% here
- 0:23Speaker 2: this morning. It unveiled a new artificial intelligence chip. and
- 0:28Speaker 2: plans for more powerful models, including what it said was
- 0:31Speaker 2: China's most powerful AI chip. It says it can deliver
- 0:35Speaker 2: three times the performance of the company's previous generation. And
- 0:39Speaker 2: it plans to train a new AI model at the
- 0:42Speaker 2: scale of five to 10 trillion parameters. I don't know
- 0:45Speaker 2: what that means. I don't know. But it sounds like
- 0:47Speaker 2: an awful, awful lot. And it says it can be
- 0:49Speaker 2: a real competitor to NVIDIA's chip.
- 0:53Speaker 1: On a similar note, I downloaded Muse app to my phone.
- 0:56Speaker 2: Oh, Meta's AI agent.
- 0:58Speaker 1: Yeah.
- 0:58Speaker 2: So now I've got like four or five of them.
- 0:59Speaker 1: I don't know what I'm doing, but it's on the phone.
- 1:01Speaker 2: It's taking up a lot of space on your phone.
- 1:03Speaker 2: You're very agnetic.
- 1:05Speaker 1: Yeah, exactly. I'm getting there. Agentic. All right.
- 1:07Speaker 2: And also, remember this- Is that how you say it?
- 1:09Speaker 1: Agentic? I don't even know how to pronounce it. Agentic AI.
- 1:10Speaker 2: Agentic. That's what our folks here say. That's the stuff
- 1:13Speaker 2: you actually use it for, right? Right. Didn't- I mean,
- 1:16Speaker 2: Ed Ludlow is a brand new baby.
- 1:17Speaker 1: Didn't he name it? Agentic AI.
- 1:19Speaker 2: Nice.
- 1:19Speaker 1: Yeah. OK.
- 1:22Speaker 2: Also, by the way, I'm sure I would imagine this
- 1:24Speaker 2: chip or what Alibaba is doing may come up during
- 1:28Speaker 2: the summit between Xi Jinping and President Trump this week.
- 1:30Speaker 2: I'm just saying. OK, now let's move on to on holding,
- 1:34Speaker 2: because we either never talk about a stock or we
- 1:36Speaker 2: talk about it like like it twice in a week,
- 1:38Speaker 2: you know. So this is the ticker symbol. Oh, and oh,
- 1:40Speaker 2: and it is up another 11 percent today. It expects
- 1:44Speaker 2: sales growth in the high teens over the next few years. Remember,
- 1:47Speaker 2: this is the Swiss sneaker maker that's trying to make
- 1:49Speaker 2: a move here and take market share away from Adidas
- 1:52Speaker 2: or Adidas in Germany and Nike. So we spoke recently
- 1:57Speaker 2: about soccer star Mbappe leaving Nike to become the face
- 2:00Speaker 2: of onholding. So the stock seems to be out with
- 2:03Speaker 2: more good news, and we're seeing it higher here, although
- 2:06Speaker 2: it is down 41% year-to-date onholding.
- 2:10Speaker 1: All right. I've seen a lot of those shoes around town.
- 2:13Speaker 1: Roger Federer owns 2.5% to 3%, it says. Oh, good.
- 2:15Speaker 1: I thought it would have been more, but still, that's
- 2:17Speaker 1: got to be huge.
- 2:17Speaker 2: That's pretty good, though. Yeah. And then let's move to biopharma. So,
- 2:22Speaker 2: Viking Therapeutics, ticker symbol VKTX. having a pretty incredible day.
- 2:27Speaker 2: The stock is up about 30% here in the pre-market.
- 2:30Speaker 2: It was up more than 50% earlier. It announced positive
- 2:34Speaker 2: top-line results from a study of dosing regimens for maintaining
- 2:38Speaker 2: weight loss. And this is really important because people keep
- 2:40Speaker 2: talking about the GLP-1s and how, yeah, the weight loss
- 2:43Speaker 2: is great while you're on them, but what happens when
- 2:45Speaker 2: you're off them? How do you maintain the weight loss? Okay.
- 2:48Speaker 2: So this study showed that this drug led to a 22%
- 2:52Speaker 2: weight loss over 33 weeks in what they call a
- 2:55Speaker 2: maintenance study. And they're saying it could be a contender
- 2:59Speaker 2: to Eli Lilly and Novo.
- 3:01Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:05Speaker 1: us throughout the day for the latest roundup of companies
- 3:08Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 3:12Speaker 1: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 3:17Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 3:20Speaker 1: Business app.